Pronounced Reductions in Plasma Citrulline Indicate Severe Intestinal Mucosal Barrier Injury During Induction Therapy for Pediatric Acute Myeloid Leukemia
European Journal of Haematology · 2026-11 · 117 (5) · 1275-1284
DOI: 10.1111/ejh.70267 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, online erschienen am 17.07.2026. Verfasst von Carla Warley Kjær und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Citrulline, Intestinal Mucosa, Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Danish Childhood Cancer Foundation, Børnecancerfonden.
Abstract (Originalsprache)
Objectives
Pediatric acute myeloid leukemia (AML) chemotherapy regimens are frequently burdened by fever episodes, systemic inflammation and bloodstream infections (BSI). Mucosal barrier injury may contribute to these complications, but its role in childhood AML remains uninvestigated. This study assessed mucosal barrier injury using plasma citrulline and examined associations with inflammation, fever, and BSI.
Methods
Twenty children (1–16 years) with AML were prospectively studied during two induction courses (NOPHO‐DBH AML 2012 protocol). Plasma citrulline was measured weekly from days 1–29 of each course.
Results
All patients exhibited marked reductions in citrulline during both inductions, reaching nadir on day 15 and recovering by day 29. C‐reactive protein (CRP) levels > 50 mg/L occurred in 19/20 patients, and 10/20 developed BSI. Fever occurred in all patients during induction I and in 16/19 during induction II. Severe mucosal damage (citrulline AUC) correlated with higher CRP and more febrile days, particularly in induction II ( r s = −0.72, p = 0.0011; r s = −0.47, p = 0.06). Patients with BSI showed lower citrulline on days 22 and 29 following induction II (11.1 vs. 16.2 μM, p = 0.024) and (10.1 vs. 17.3 μM, p = 0.012).
Conclusions
Pediatric AML treatment causes significant mucosal barrier injury, which is associated with inflammatory and infectious complications and may represent a target for supportive interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Pediatrics, Amager and Hvidovre Hospital, Hvidovre, Denmark.
- Department of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
- Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark.
ORCID-Profile: Maria Ebbesen Sørum, Marianne Hoffmann, Sarah Weischendorff, Klaus Müller
Förderung
- Danish Childhood Cancer Foundation
- Børnecancerfonden
Zitieren
APA
Kjær, C. W., Sørum, M. E., De Pietri, S., Moser, C., Petersen, M. J., Hoffmann, M., Hasle, H., Weischendorff, S., & Müller, K. (2026). Pronounced Reductions in Plasma Citrulline Indicate Severe Intestinal Mucosal Barrier Injury During Induction Therapy for Pediatric Acute Myeloid Leukemia. European Journal of Haematology, 117(5), 1275-1284. https://doi.org/10.1111/ejh.70267
Vancouver
Kjær CW, Sørum ME, De Pietri S, Moser C, Petersen MJ, Hoffmann M, et al. Pronounced Reductions in Plasma Citrulline Indicate Severe Intestinal Mucosal Barrier Injury During Induction Therapy for Pediatric Acute Myeloid Leukemia. European Journal of Haematology. 2026;117(5):1275-1284. doi:10.1111/ejh.70267
BibTeX
@article{Kjr2026,
author = {Kjær, Carla Warley and Sørum, Maria Ebbesen and De Pietri, Silvia and Moser, Claus and Petersen, Malene Johanne and Hoffmann, Marianne and Hasle, Henrik and Weischendorff, Sarah and Müller, Klaus},
title = {Pronounced Reductions in Plasma Citrulline Indicate Severe Intestinal Mucosal Barrier Injury During Induction Therapy for Pediatric Acute Myeloid Leukemia},
journal = {European Journal of Haematology},
year = {2026},
volume = {117},
number = {5},
pages = {1275--1284},
doi = {10.1111/ejh.70267}
}
EUVIMED